These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 34748616)
41. The BRRF1 early gene of Epstein-Barr virus encodes a transcription factor that enhances induction of lytic infection by BRLF1. Hong GK; Delecluse HJ; Gruffat H; Morrison TE; Feng WH; Sergeant A; Kenney SC J Virol; 2004 May; 78(10):4983-92. PubMed ID: 15113878 [TBL] [Abstract][Full Text] [Related]
42. ΔNp63α is a super enhancer-enriched master factor controlling the basal-to-luminal differentiation transcriptional program and gene regulatory networks in nasopharyngeal carcinoma. Cai J; Chen S; Yi M; Tan Y; Peng Q; Ban Y; Yang J; Li X; Zeng Z; Xiong W; McCarthy JB; Li G; Li X; Xiang B Carcinogenesis; 2020 Sep; 41(9):1282-1293. PubMed ID: 31826234 [TBL] [Abstract][Full Text] [Related]
43. The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma. Tsang CM; Tsao SW Virol Sin; 2015 Apr; 30(2):107-21. PubMed ID: 25910483 [TBL] [Abstract][Full Text] [Related]
44. Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner. Ellis AL; Wang Z; Yu X; Mertz JE J Virol; 2010 Jun; 84(12):6139-52. PubMed ID: 20375168 [TBL] [Abstract][Full Text] [Related]
45. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Promotes EBV Reactivation through Activation of the p38 Mitogen-Activated Protein Kinase. Liu X; Cohen JI J Virol; 2016 Jan; 90(2):1129-38. PubMed ID: 26559845 [TBL] [Abstract][Full Text] [Related]
46. Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic Reactivation. Murata T; Sugimoto A; Inagaki T; Yanagi Y; Watanabe T; Sato Y; Kimura H Viruses; 2021 Nov; 13(12):. PubMed ID: 34960613 [TBL] [Abstract][Full Text] [Related]
47. LMP1 Induces p53 Protein Expression via the H19/miR-675-5p Axis. Li J; Zhang Y; Sun L; Liu S; Zhao M; Luo B Microbiol Spectr; 2022 Jun; 10(3):e0000622. PubMed ID: 35674441 [TBL] [Abstract][Full Text] [Related]
48. Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells. Lo AK; Lo KW; Tsao SW; Wong HL; Hui JW; To KF; Hayward DS; Chui YL; Lau YL; Takada K; Huang DP Neoplasia; 2006 Mar; 8(3):173-80. PubMed ID: 16611410 [TBL] [Abstract][Full Text] [Related]
49. Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors. Feng WH; Westphal E; Mauser A; Raab-Traub N; Gulley ML; Busson P; Kenney SC J Virol; 2002 Nov; 76(21):10951-9. PubMed ID: 12368338 [TBL] [Abstract][Full Text] [Related]
51. MYC Controls the Epstein-Barr Virus Lytic Switch. Guo R; Jiang C; Zhang Y; Govande A; Trudeau SJ; Chen F; Fry CJ; Puri R; Wolinsky E; Schineller M; Frost TC; Gebre M; Zhao B; Giulino-Roth L; Doench JG; Teng M; Gewurz BE Mol Cell; 2020 May; 78(4):653-669.e8. PubMed ID: 32315601 [TBL] [Abstract][Full Text] [Related]
52. Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells. Lo AK; Dawson CW; Young LS; Ko CW; Hau PM; Lo KW J Pathol; 2015 Oct; 237(2):238-48. PubMed ID: 26096068 [TBL] [Abstract][Full Text] [Related]
53. IRF4 promotes Epstein-Barr virus activation in Burkitt's lymphoma cells. Gao Y; Wang L; Lei Z; Li J; Forrest JC; Liang X J Gen Virol; 2019 May; 100(5):851-862. PubMed ID: 30907723 [TBL] [Abstract][Full Text] [Related]
54. Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes. Guidry JT; Myers JE; Bienkowska-Haba M; Songock WK; Ma X; Shi M; Nathan CO; Bodily JM; Sapp MJ; Scott RS J Virol; 2019 Jan; 93(2):. PubMed ID: 30381489 [TBL] [Abstract][Full Text] [Related]
55. Type 1 and Type 2 Epstein-Barr viruses induce proliferation, and inhibit differentiation, in infected telomerase-immortalized normal oral keratinocytes. Singh DR; Nelson SE; Pawelski AS; Cantres-Velez JA; Kansra AS; Pauly NP; Bristol JA; Hayes M; Ohashi M; Casco A; Lee D; Fogarty SA; Lambert PF; Johannsen EC; Kenney SC PLoS Pathog; 2022 Oct; 18(10):e1010868. PubMed ID: 36190982 [TBL] [Abstract][Full Text] [Related]
56. Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer. Chia MC; Leung A; Krushel T; Alajez NM; Lo KW; Busson P; Klamut HJ; Bastianutto C; Liu FF Clin Cancer Res; 2008 Feb; 14(4):984-94. PubMed ID: 18281530 [TBL] [Abstract][Full Text] [Related]
57. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma. Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360 [TBL] [Abstract][Full Text] [Related]
58. The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers. Tsai MH; Lin X; Shumilov A; Bernhardt K; Feederle R; Poirey R; Kopp-Schneider A; Pereira B; Almeida R; Delecluse HJ Oncotarget; 2017 Feb; 8(6):10238-10254. PubMed ID: 28052012 [TBL] [Abstract][Full Text] [Related]
59. Ceramide promotes lytic reactivation of Epstein-Barr virus in gastric carcinoma. Kim JY; Min YJ; Lee M-H; An YR; Ashktorab H; Smoot DT; Kwon SW; Lee SK J Virol; 2024 Feb; 98(2):e0177623. PubMed ID: 38197630 [TBL] [Abstract][Full Text] [Related]
60. Detection of methylation status of Epstein-Barr virus DNA C promoter in the diagnosis of nasopharyngeal carcinoma. Zheng XH; Wang RZ; Li XZ; Zhou T; Zhang JB; Zhang PF; Lu LX; Jia WH Cancer Sci; 2020 Feb; 111(2):592-600. PubMed ID: 31834989 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]